Skip to main content

Sonnet BioTherapeutics Holdings, Inc.

SONNDelisted Dec 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001106838

Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.

Superinvestors holding SONN, Q3 2025

See all superinvestors

No superinvestor reported holding SONN in Q3 2025.